# Zenas BioPharma (ZBIO) — Earnings

ZBIO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/zbio/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q1 2025 |
| Period end | Mar 31, 2025 |
| EPS actual | −$0.80 |
| EPS estimate | −$1.13 |
| EPS surprise | +29.43% |
| Revenue surprise | +500.00% |
| Revenue | $10.0M |
| Revenue estimate | $1.7M |
| Reported | May 15, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1953926/000155837025007803/zbio-20250331x10q.htm) |

Zenas BioPharma's most recent quarter in the table is Q1 2025, reported on May 15, 2025. The company posted a loss of $0.80 per share, narrower than the $1.13 loss analysts expected, a 29.43% beat. Revenue was $10.0 million, far above the $1.7 million estimate. The table has no Q1 2024 row, so there is no year-over-year comparison.

The record here is very short: Q1 2025 is the only quarter listed. That makes it impossible to describe a trend in earnings or revenue, to total a fiscal year, or to count beats and misses over time. A single quarter shows one loss and one revenue figure, nothing more. Readers looking for a fuller history will not find it in this data, and the summary does not try to fill the gap.

The table also has no reports after May 2025, so it does not show the quarters that followed. There is no pattern of report dates to estimate when the next set of results will appear here. Once later quarters are added, the page will show whether the loss per share narrows or widens and how revenue compares with this first reported quarter of $10.0 million.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q1 2025 | May 15, 2025 | −$1.13 | −$0.80 | 29.43% | $1.7M | $10.0M |

## Frequently Asked Questions

### When did Zenas BioPharma (ZBIO) last report earnings?

Zenas BioPharma last reported on May 15, 2025, covering fiscal Q1 2025.

### Did ZBIO beat earnings estimates?

Yes. Zenas BioPharma reported EPS of −$0.80 for Q1 2025 against a −$1.13 estimate — a 29.43% beat.

### How much revenue did ZBIO report last quarter?

Zenas BioPharma reported $10.0M in revenue for Q1 2025, against a consensus estimate of $1.7M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).